Scailyte Company

Scailyte is a company that specializes in biomarker discovery using a data-driven platform that combines single-cell data analysis and artificial intelligence. They focus on discovering disease-associated biomarkers using a phenotypic approach, which increases the success rate of discovering sensitive and robust biomarkers. Scailyte also develops analytical pipelines to translate data into clinical applications through single-cell science.


Estimated Revenue: Less than $1M
Funding Status: Early Stage Venture
Headquarters: Basel, Basel-Stadt, Switzerland
Total Funding: 13747507
Last Funding Date: 2022-09-21
Investors Number: 8
Number Of Exists: 11-50
Founded Date: 2017
Technology: Artificial Intelligence, Biotechnology, Health Diagnostics, Medical
Industry: Omics-Based Biomarkers
Last Funding Type: Series A
Employee Number: 11-50